LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice.

Michael V TulliusRichard A BowenPeter S BackSaša Masleša-GalićSusana NavaMarcus A Horwitz

Published in: mBio (2024)

; this vector platform has previously been used successfully to develop potent vaccines against other Tier 1 select agent diseases including tularemia, anthrax, and plague.

Keyphrases

high fat diet induced
high throughput
anti inflammatory
fluorescent probe
type diabetes
molecularly imprinted
living cells
mass spectrometry
metabolic syndrome
skeletal muscle
single cell
adipose tissue
wild type
high resolution